SEROMYCIN is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Parsolex Gmp Center, Inc.. The primary component is Cycloserine.
Product ID | 13845-1200_b67c1b1d-7687-427a-a07a-e8100c046f73 |
NDC | 13845-1200 |
Product Type | Human Prescription Drug |
Proprietary Name | SEROMYCIN |
Generic Name | Cycloserine |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2009-03-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA060593 |
Labeler Name | Parsolex Gmp Center, Inc. |
Substance Name | CYCLOSERINE |
Active Ingredient Strength | 250 mg/250mg |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2009-03-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA060593 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-03-01 |
Marketing Category | ANDA |
Application Number | ANDA060593 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-03-01 |
Ingredient | Strength |
---|---|
CYCLOSERINE | 250 mg/250mg |
SPL SET ID: | e1e08327-4b90-463e-bb2a-22438cabcef2 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
13845-1200 | SEROMYCIN | CYCLOSERINE |
13845-1203 | Seromycin | CycloSERINE |
13845-1201 | CYCLOSERINE | CYCLOSERINE |
13845-1202 | Cycloserine | Cycloserine |
33342-462 | Cycloserine | Cycloserine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() SEROMYCIN 88630156 not registered Live/Pending |
Parsolex GMP Center, Inc. 2019-09-25 |
![]() SEROMYCIN 72016353 0649601 Live/Registered |
ELI LILLY AND COMPANY 1956-09-25 |